Skip to content

Acute Intestinal Necrosis- the Preoperative Diagnostic Approach

Acute Intestinal Ischaemia: the Preoperative Diagnostic Approach

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05665946
Acronym
AIN
Enrollment
2958
Registered
2022-12-27
Start date
2015-01-06
Completion date
2019-03-24
Last updated
2022-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Mesenteric Ischemia

Brief summary

To investigate a number of blood based parameters in patients with intestinal ischaemia compared to patients with other acute abdominal diseases.

Detailed description

Intestinal ischemia is a life-threatening condition defined by interrupted blood supply to the intestinal tissue. Primary and secondary ischemia is obstruction of blood-supply due to vascular and extra-vascular pathology, respectively. Early diagnosis and treatment are critical to save the ischemic bowel. Clinical findings of secondary intestinal ischaemia are related to the underlying cause e.g. vomiting and palpable hernia. Abdominal computed tomography (CT) can effectively visualize the causes. In contrast, the diagnosis of primary intestinal ischemia is often delayed due to the absence of specific clinical findings. Primary intestinal ischemia is visualized with CT ateriography, revealing mesentery arterial obstruction. However, in the acute setting a non-arterial phase CT is often performed but the findings are unspecific in the early stages and the pattern of findings which could indicate primary ischemia are not well understood. In primary and secondary ischemia, standard blood-based parameters are inconsistently elevated and highly unspecific. Newer blood-based parameters such as D-lactate has been proposed as ischaemic markers. D-lactate is produced by bacteria in the bowel lumen and translocation through a damaged bowel wall makes it a potential marker of intestinal ischemia. A case-control-study of all acute admitted patients with abdominal pain in Aalborg, Denmark in the mentioned time range. The sensitivity and specificity of potiential biomarkers in a blood sample at time of admission as a marker of intestinal ischaemia will be examined.

Interventions

DIAGNOSTIC_TESTBlood sample analysis

Analysis of proposed biomarkers.

Sponsors

Aalborg University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* Referred to The Department of Gastrointestinal Surgery, Aalborg University Hospital.

Exclusion criteria

* Children

Design outcomes

Primary

MeasureTime frameDescription
D-lactate2015-2019, Just after inclusionMeasurement of baseline level of D-lactate as a predictor of AIN
I-FABP2015-2019, Just after inclusionMeasurement of baseline level of I-FABP as a predictor of AIN.
Endothelin-12015-2019, Just after inclusionMeasurement of baseline level of Endothelin-1 as a predictor of AIN
L-lactate2015-2019, Just after inclusionMeasurement of baseline level of L-lactate as a predictor of AIN

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026